Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
复制标题
DOI:
10.1002/cncr.29857
复制
发表时间:
2016-03-15
期刊:
影响因子:
6.2
通讯作者:
Giordano SH
中科院分区:
文献类型:
--
作者:
Lin SH;Zhang N;Godby J;Wang J;Marsh GD;Liao Z;Komaki R;Ho L;Hofstetter WL;Swisher SG;Mehran RJ;Buchholz TA;Elting LS;Giordano SH
It is currently unclear if the superior normal organ sparing effect of Intensity Modulated Radiation Therapy (IMRT) as compared to three-dimensional radiation therapy (3D) has clinical impact on survival and cardiopulmonary mortality in esophageal cancer (EC) patients. We identified 2,553 patients older than age 65 years from the SEER/Texas Cancer Registry-Medicare databases who had non-metastatic EC diagnosed between 2002 and 2009 and were treated with either 3D (n=2,240) or IMRT (n=313) within 6 months of diagnosis. The outcomes of the two cohorts were compared using Inverse Probability of Treatment Weighting (IPTW) adjustment. Except for marital status, year of diagnosis, and SEER region, both radiation cohorts were well balanced for various patient, tumor, and treatment characteristics, including the use of IMRT vs. 3D in urban/metro or rural areas. IMRT use increased from 2.6% in 2002 to 30% in 2009, while 3D use decreased from 97.4% in 2002 to 70% in 2009. On propensity score IPTW-adjusted multivariate analysis, IMRT was not associated with EC-specific mortality (HR 0.93, 95%CI 0.80-1.10) or pulmonary mortality (HR 1.11, 95%CI 0.37-3.36) but was significantly associated with lower all-cause mortality (HR 0.83, 95%CI 0.72-0.95), cardiac mortality (HR 0.18, 95%CI 0.06-0.54) and other cause mortality (HR 0.54, 95%CI 0.35-0.84). Similar associations were seen after adjusting for the type of chemotherapy, physician experience, and sensitivity analysis removing hybrid radiation claims. In this population-based analysis, IMRT use was significantly associated with lower all-cause mortality, cardiac mortality, and other-cause mortality in EC patients. It is currently unclear if the dosimetric advantages of organ sparing by Intensity Modulated Radiation Therapy (IMRT) compared to three dimensional conformal radiation therapy (3D) can translate to survival and cardiopulmonary mortality benefit in esophageal cancer patients. This SEER/Texas Cancer Registry-Medicare population-based study found that while there were no differences in cancer or pulmonary-specific mortality, all-cause and cardiac-specific mortality were significantly reduced in IMRT-treated patients under a propensity score adjusted multivariate analysis.
登录
查看更多内容
DOI:
10.1016/j.ijrobp.2009.02.032
发表时间:
2010-03-01
影响因子:
7
作者:
Liao, Zhongxing X.;Komaki, Ritsuko R.;Cox, James D.
通讯作者:
Cox, James D.
影响因子:
158.5
作者:
Darby, Sarah C.;Ewertz, Marianne;Hall, Per
通讯作者:
Hall, Per
DOI:
10.1016/j.ijrobp.2013.04.006
发表时间:
2013-08-01
影响因子:
7
作者:
Wang, Jingya;Wei, Caimiao;Tucker, Susan L.;Myles, Bevan;Palmer, Matthew;Hofstetter, Wayne L.;Swisher, Stephen G.;Ajani, Jaffer A.;Cox, James D.;Komaki, Ritsuko;Liao, Zhongxing;Lin, Steven H.
通讯作者:
Lin, Steven H.
影响因子:
8.8
作者:
Henson, K. E.;McGale, P.;Taylor, C.;Darby, S. C.
通讯作者:
Darby, S. C.
影响因子:
7.8
作者:
Lohia, Shivangi;Rajapurkar, Mayuri;Day, Terry A.
通讯作者:
Day, Terry A.